SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
57 hedge funds and large institutions have $240M invested in Syros Pharmaceuticals, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 10 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
63% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 19
Holders
57
Holding in Top 10
1
Calls
$332K
Puts
$111K
Top Buyers
| 1 | +$13.2M | |
| 2 | +$11.5M | |
| 3 | +$8.7M | |
| 4 |
BlackRock
New York
|
+$4.6M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.37M |
Top Sellers
| 1 | -$4.95M | |
| 2 | -$2.88M | |
| 3 | -$2.67M | |
| 4 |
AIC
AWM Investment Company
New York
|
-$632K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$330K |